With over 2,500 drive systems sold, deployed and integrated, Enova clean vehicle technologies are powering fleets around the globe — today. Our established customer base includes the world’s largest manufacturers of commercial trucks and buses, among them Navistar, Freightliner Custom Chassis (a division of Daimler Trucks North America), Smith Electric Vehicles, Hyundai, Ford, Wrightbus, Isuzu, Eco Power Technology, and many more.

Our proprietary clean vehicle technologies are built on more than three decades of research, development and innovation. In that time, we’ve continued refining our solutions and driving value for vehicle manufacturers as well as their fleet customers.

Enova Systems, Inc. (NYSE AMEX:ENA), a leading developer of proprietary hybrid electric and all-electric drive systems and drive system components for the emerging green commercial vehicle market, announces revenues and gross margin growth for Q4 2010 and for the 2010 year. Additionally the company highlights a production intent battery supply from Compact Power Inc., a subsidiary of LG Chem.

GROWTH HIGHLIGHTS:

* $3.7M in revenue for Q4 2010, up more than 151% over the same period in 2009
* 20.4% gross margin for Q4 2010 with gross profit up 327% over the same period in 2009 result as one of the best quarters on record for Enova
* Annual revenue growth from $5.6M in 2009 to $8.6M in 2010, a 52% increase
* Overall annual gross margin increase from 10.8% in 2009 to 16.5% in 2010
* Moved from an overall gross margin loss of 74.1% in 2006 to 16.5% positive gross margin in 2010

Enova President and CEO Mike Staran stated, “2010 resulted in quarter after quarter positive gross margin growth, responsible cash management and core customer growth. Exciting partnerships with companies like LG Chemical further confirm our technology and allow us to penetrate incremental opportunities within the expanding market.”

TECHNOLOGY HIGHLIGHTS:

* OMNI INVERTER: Power-source agnostic, Enova’s new Omni-series inverter offers increased flexibility and ease-of-integration. With plug-and-play connectivity, it is compatible with a wide range of vehicle drive systems and motors, and can be configured for HEV, PHEV and EV applications.

* OMNI CHARGER: Enova launched plans to develop and validate its next-generation of power electronics with the new Omni-series 10kVA power on-board charger for hybrid-electric and all-electric vehicles. The new Omni-series charger also offers increased flexibility, ease-of-integration and compatibility with a wide range of vehicle platforms.

* LGCPI Battery Supply: Enova Systems announces a partnership with LGCPI, the North American subsidiary of LG Chem Ltd. LGCPI intends to produce and supply power-oriented battery packs on Enova’s charge-sustaining post-transmission hybrid systems. LG Chem clients include General Motors Co., Volvo AB, Ford Motor Co., Renault, Eaton, Navistar and China’s Chongqing Changan Automobile Co. The company’s EV battery business is expected to generate $901 million in sales by 2013. Combined with Enova’s new Omni inverter, the LGCPI packs will provide Enova’s customers with the most advanced and robust medium duty truck and bus hybrid systems available. The combined technologies will also offer strong value and performance to the end user.

* BATTERIES: Enova continues to mature its long-standing relationship with Valence on energy-oriented battery packs, as well as evaluate technologies offered by A123, Samsung/Bosch and Dow Kokam.

* REMY: Enova and Remy have executed a letter of intent to develop a new electric drive system based on Enova’s next generation Omni controller and Remy HVH250 motor. Remy is North America’s largest independent manufacturer of advanced electric propulsion motors. Remy’s patented design and assembly technology have been in production since 2006 and are currently powering vehicles around the world.

Enova applies unique ‘enabling technologies’ in the areas of alternative energy propulsion systems for light and heavy-duty vehicles as well as power conditioning and management systems for distributed generation systems. The Company develops, designs and produces non-invasive drive systems and related components for electric, hybrid-electric, and fuel cell powered vehicles in both the “new” and “retrofit” vehicle sales market.

**************************************************************************

Power3 Medical Products, Inc. (PWRM)
Alzheimer’s disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, and eventually even the ability to carry out the simplest tasks. In most people with Alzheimer’s, symptoms first appear after age 60. The main risk factor for Alzheimer’s disease is increased age. As a population ages, the frequency of Alzheimer’s disease continues to increase. Ten percent of people over 65 years of age and 50% of those over 85 years of age have Alzheimer’s disease. Unless new treatments are developed to decrease, Alzheimer’s is predicted to affect 1 in 85 people globally by 2050.
The earliest observable symptoms are often mistakenly thought to be ‘age-related’ concerns, or manifestations of stress. In the early stages, the most commonly recognised symptom is inability to acquire new memories, such as difficulty in recalling recently observed facts. When AD is suspected, the diagnosis is usually confirmed with behavioural assessments and cognitive tests, often followed by a brain scan if available.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.

BC-SeraPro™ of Power3 Medical Products, Inc is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient’s serum sample is compared to the Power3 Medical Products’ patient database. Statistical analysis by linear discriminant function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis of the patient sample. Probability score is ranged from 0.0 to 1.0. Results of the BC-SeraPro™ test should not be considered a standalone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.

For more information about Power3 Medical Products, Inc. visit its website http://www.power3medical.com

********************************************************************************

Smokefree Innotec, Inc. (SFIO)
Smoking causes lung disease, heart and blood vessel disease, cancer, and other illness. One of four smokers dies of diseases directly related to smoking. Many others suffer years of pain, ill health, and discomfort. Smoking also causes direct injury to your artery walls and promotes fat build-up in them. You may experience circulation problems such as cold feet, occasional pins and needles, and numbness in the leg. At an advanced stage, the disease may result in gangrene, which could lead to the amputation of your legs. Nineteen out of twenty people suffering from this disabling disease are cigarette smokers.

Cigarette smoking increases your risk of dying from lung cancer by 8 to 20 times. Nine out of ten people who die from lung cancer are smokers. Smoking increases the risk of developing cancer of the mouth, throat, and esophagus by two to twenty times. The risk of cancer also increases even in organs not directly exposed to tobacco smoke. These include the pancreas, kidneys, urinary bladder, and probably the cervix.

The average consumer has been bombarded with negative information about cigarettes for years. An estimated 400,000 American persons die from smoking related deaths each year. Tobacco cigarettes have been found to cause cancer and cardio vascular disease, and are linked to high blood pressure and diabetes, among other illnesses. Even second hand smoke has been proven to have adverse medical affects. Because of this, many states and counties within the United States have banned smoking in public places, leaving many smokers out in the cold, sometimes literally.

Electronic cigarettes have a similar look as traditional cigarettes. Since the e-cigarettes are non-flammable and do not contain tobacco, one has the freedom of smoking virtually everywhere. The cigarettes are rechargeable and use advanced micro-electronic technology to deliver nicotine to the user. The nicotine cartridges come in a variety of concentrations making it easy to slowly breakdown the intake.

Smokefree Innotec’s products are designed to protect the non-smoker from second hand smoke and all its effects while providing the smoker a way to enjoy a smoke-free cigarette anywhere, including places where smoking tobacco or similar substances is prohibited. Further, products would allow the smoker to enjoy smoking either nicotine or flavored non-nicotine cigarettes while not having to worry about the offensive dangers and ill effects of regular cigarette smoking. However Smokefree Innotec products are not intended for any prevention or therapeutic treatment of any disease.

Smokefree Innotec, Inc recently declared that with some minor fine tuning, their shopping cart is now fully operational giving their customers the opportunity to purchase the first of their products being offered: Smokers Option, in both Menthol and Cinnamon. The web site itself is undergoing extensive redesign, to include complete product description located in easy to access click through portals. Beginning with Smokers Option presently available, additional products expected to be offered soon include ’smokeless REAL e-cigarettes’ (pronounced ‘Re-Al’).

About Smokefree Innotec, Inc: www.smokefree-innotec.com/

**********************************************

Energy Focus, Inc. (Nasdaq:EFOI) announced that it has recently completed a full lighting retrofit of Truline Industries, Inc.’s Chesterland, OH Precision Machining Facility using Energy Focus’ LED G1 IntelliTube(TM) fluorescent replacement lamps, LED TrackLights and LED LandScapes.

Energy Focus, Inc. engages in the design, development, manufacture, marketing, and installation of energy-efficient lighting systems principally for commercial/industrial lighting and pool lighting markets.

**********************************************

Parkervision Inc. (Nasdaq:PRKR) announced the closing of its previously announced offering of 3,332,117 shares of its common stock at a price of $0.71 per share and 2,691,360 units, each unit consisting of one share of common stock and 0.3 of a warrant to purchase common stock, at an offering price of $0.81 per unit in a registered offering primarily to institutional investors. The warrants have an exercise price of $0.88 per share and are exercisable during the five-year period commencing September 30, 2011.

ParkerVision, Inc. engages in the design, development, and sale of proprietary radio frequency (RF) technologies and products for use in semiconductor circuits for wireless communication products.

**********************************************

Labopharm Inc. (Nasdaq:DDSS) announced on March 22, 2011 that it has reduced its workforce, eliminating 38 positions. “Although a difficult decision, today’s action will provide the Corporation with additional cost savings as the board of directors and senior management team continue a complete review of the business, including consideration of all available strategic options, as announced last week,” said Mark D’Souza, President and Chief Executive Officer of Labopharm Inc.

Labopharm Inc., a specialty pharmaceutical company, develops drugs by incorporating its proprietary controlled-release technologies. It offers once-daily formulation of the analgesic tramadol under the RYZOLT brand name for the treatment of severe chronic pain in adults.

Sign up for free stock alerts at http://www.pennygovernance.com/signup

***************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyGovernance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyGovernance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.(read more @ http://pennygovernance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).
Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars in cash for one week (which has expired) of advertising services and anticipates receiving another five thousand dollars in cash for one month of advertising services from a third party (Stock Expert) for Smokefree Innotec, Inc. (SFIO.PK).